Ronald Chen, MD
UNC Hospitals Cancer Center
Area of Interest
Primary clinical interests are in 1) genitourinary cancers and 2) Cyberknife radiation.
Cyberknife is an exciting new technology, and could represent a more accurate way to deliver radiation because of an ability to “track” the movement of the tumor (target) during radiation. The University of North Carolina is one of the few academic centers in the United States with a Cyberknife and a clinical trial for prostate cancer patients (4 radiation treatments) is being offered.
Primary research interest involves the long-term outcomes of prostate cancer patients and survivors. This includes bringing new prostate cancer treatments to the clinic, clinical trials, and studying/comparing the efficacy and long-term quality of life effects of current treatments (including surgery and radiation) for prostate cancer.
The long-term quality of life impact of prostate cancer treatments is increasingly recognized as an important consideration in the decision-making process for a patient. For men with localized prostate cancer, most become long-term survivors, but the treatments they chose and received may leave long-lasting quality of life effects and symptoms. Surgery, external beam radiation, and brachytherapy are all accepted standard treatments for localized prostate cancer, but they cause distinctly different short-term and long-term side effects. One of Dr. Chen?s main research interests is in studying the quality of life of prostate cancer survivors, and to bring this information to clinical use by counseling patients prior to choosing treatment.
Awards and Honors
•2017 UNC Health Care and Faculty Physicians Carolina Care Excellence Leader
•2016 ASCO Advocacy Champion
•2016 Carolina Care Excellence Award
•2014 UNC Alpha Omega Alpha (AOA) Faculty Member inductee
•2013 UNC James W. Woods Junior Faculty Development Award
•2013 Association of Residents in Radiation Oncology (ARRO) Educator of the Year
•2013 Inducted as Member of UNC School of Medicine Academy of Educators
•2012 UNC School of Medicine Academy of Educators Medical Student Research Mentor Award
•2011 Department of Radiation Oncology Excellence in Teaching Award
•2010 University of North Carolina Junior Faculty Development Award
•2009 ASCO/AACR Methods in Clinical Research (Vail Workshop)
•2009 ASCO Cancer Foundation Merit Award
•2008 Radiation Therapy Oncology Group (RTOG) Meeting Travel Grant
•2007 CaPSURE Scholar: UCSF Cancer of the Prostate Strategic Urologic Research Endeavor
•2006 Travel grant, American Society for Therapeutic Radiology and Oncology Health Services/Outcomes Research in Oncology Symposium
•2004 Cum laude (Harvard Medical School)
•2001 Doris Duke Clinical Research Fellow
•2001 Leopold Schepp Foundation Scholarship
•2000 Harvard Medical School PASTEUR Fellow – Patient-Associated Science: Training, Education, Understanding, and Research
•1999 Highest Distinction (equivalent to summa cum laude), University of Kansas
•1996 Barry M. Goldwater Scholar